Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liporaxel Biodistribution in Solid Tumors
NCT04046016Phase 1Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2018
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of paclitaxel in solid tumor, sponsored by Seoul National University Hospital. Primary endpoints: Maximum Plasma Concentration at 10 hours and Area Under the Curve to the Last Measurable Concentration at 10 hours. Started Jul 2018; status: completed.
02
Drugs
paclitaxel
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04046016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04046016.